Appointment of Agent for Service of Process and Undertaking (f-x)
February 07 2018 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
F-X
APPOINTMENT
OF AGENT FOR SERVICE
OF PROCESS AND UNDERTAKING
|
|
|
|
|
|
|
A.
|
|
Name of issuer or person filing (Filer):
|
|
Aptose Biosciences Inc.
|
|
|
|
B.
|
|
(1)
|
|
This is (check one):
|
|
|
|
|
|
☒
|
|
An original filing for the Filer.
|
|
|
|
|
|
☐
|
|
An amended filing for the Filer.
|
|
|
|
|
|
(2)
|
|
Check the following box if you are filing the Form
F-X
in paper in accordance with Regulation
S-T
Rule 101(b)(9) ☐
|
|
|
C.
|
|
Identify the filing in conjunction with which this form is being filed:
|
|
|
|
|
|
Name of registrant:
|
|
Aptose Biosciences Inc.
|
|
|
|
|
|
Form type:
|
|
Form
F-10
|
|
|
|
|
|
File number (if known):
|
|
333-222909
|
|
|
|
|
|
Filed by:
|
|
Aptose Biosciences Inc.
|
|
|
|
|
|
Date filed (if filed concurrently, so indicate):
|
|
February 7, 2018 (filed concurrently)
|
|
|
D.
|
|
The Filer is incorporated or organized under the laws of
Canada,
and has its principal place of business at
5955 Airport Road, Suite #228,
Mississauga, Ontario L4V 1R9,
Canada;
telephone (647)
479-9828.
|
|
|
E.
|
|
Filer designates and appoints
Aptose Biosciences U.S. Inc.
(Agent), located at
Unit 120, 12770 High Bluff Drive,
San Diego, California 92130;
telephone (858)
926-2730
as the agent of the Filer upon whom
may be served any process, pleadings, subpoenas, or other papers in:
(a) any
investigation or administrative proceeding conducted by the Commission; and
(b) any
civil suit or action brought against the Filer or to which the Filer has been joined as defendant or respondent, in any appropriate court in any place subject to the jurisdiction of any state or of the United States, or of any of its territories or
possessions or of the District of Columbia, where the investigation, proceeding or cause of action arises out of or relates to or concerns any offering made or purported to be made in connection with the securities registered or qualified by the
Filer on Form
F-10
on February 7, 2018 or any purchases or sales of any security in connection therewith. The Filer stipulates and agrees that any such civil suit or action or administrative proceeding may be
commenced by the service of process upon, and that the service of an administrative subpoena shall be effected by service upon such agent for service of process, and that service as aforesaid shall be taken and held in all courts and administrative
tribunals to be valid and binding as if personal service thereof had been made.
|
|
|
F.
|
|
The Filer stipulates and agrees to appoint a successor agent for service of process and file an amended Form
F-X
if the Filer discharges the Agent or the Agent is unwilling or unable to accept service on behalf of the Filer at any time until six years have elapsed from the date the issuer of the securities to which the
Form
F-10
relates has ceased reporting under the Exchange Act.
The Filer further undertakes to advise the Commission promptly of any change to the Agents name and address during the applicable period by amendment of
this Form, referencing the file number of the relevant form in conjunction with which the amendment is being filed.
|
|
|
G.
|
|
The Filer undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff,
information relating to: the Form
F-10;
the securities to which the Form
F-10
relates; and the transactions in such securities.
|
SIGNATURES
The Filer certifies that it has duly caused this power of attorney, consent, stipulation and agreement to be signed on its behalf by the
undersigned, thereunto duly authorized, in San Diego, California, on February 7, 2018.
|
|
|
APTOSE BIOSCIENCES INC.
|
|
|
By:
|
|
/s/ William G. Rice
|
|
|
Name: William G. Rice
|
|
|
Title: Chairman, President and Chief Executive Officer
|
This statement has been signed by the following person in the capacity indicated on February 7, 2018.
|
|
|
APTOSE BIOSCIENCES U.S. INC.
as Agent for Service of Process for Aptose Biosciences Inc.
|
|
|
By:
|
|
/s/ William G. Rice
|
|
|
|
Name:
|
|
William G. Rice
|
Title:
|
|
Chief Executive Officer
|
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Sep 2023 to Sep 2024